Third World “refugees” flooding into Europe are sixty-six times more likely to suffer from psychotic illnesses such as schizophrenia than Europeans, a new study has found.
As these diseases are genetic, this means that the nonwhite invasion is literally importing hundreds of thousands of mentally ill people into Europe.
The study, produced by Sweden’s Karolinska Institutet and Britain’s University College London and published in the British Medical Journal (BMJ), found that there was a “high psychosis risk” among the flood of nonwhite invaders currently entering Europe.
The scientists used national register data to look at more than 1.3 million people in Sweden, and tracked diagnoses of non-affective psychotic disorders among the population.
On a per capita basis, Sweden has granted more “refugee” applications than any other high-income country, the researchers said, and in 2011 refugees constituted 12 percent of the immigrant population.
Those studied included people born to two Swedish-born parents, “refugees,” and “non-refugee” migrants from the four major nonwhite regions: the Middle East and north Africa, sub-Saharan Africa, and Asia, and also immigrants from Eastern Europe and Russia.
Their results showed a total of 3,704 cases of psychotic disorders, with “refugees” who had been granted asylum some 66 percent more likely to develop schizophrenia or another psychotic disorder than “non-refugee” migrants—in other words, the white immigrants from eastern Europe and Russia.
“Refugees” were also up to 3.6 times more likely to suffer psychosis than the Swedish-born population.
Another recent study has found that the risk of schizophrenia is 35 times higher with just one faulty gene and is involved in a range of neurodevelopmental disorders.
It is the first time changes to the DNA code of one gene have been so strongly linked to schizophrenia.
The discovery, reported in the journal Nature Neuroscience, suggests that schizophrenia shares common biological pathways with developmental disorders.
According to the US Department of Health and Human Services’ National Institute of Mental Health (NIMH) agency, symptoms of schizophrenia include hallucinations, delusions, thought disorders, movement disorders, and “negative cognitive symptoms.”
These latter disorders include “poor executive functioning” (the ability to understand information and use it to make decisions); trouble focusing or paying attention; and problems with “working memory” (the ability to use information immediately after learning it).
Poor cognition is related to worse employment and social outcomes, the NIMH added.
The NIMH also confirmed that the causes of these diseases are genetic:
Scientists have long known that schizophrenia sometimes runs in families. The illness occurs in less than 1 percent of the general population, but it occurs in 10 percent of people who have a first-degree relative with the disorder, such as a parent, brother, or sister.
Different Brain Chemistry and Structure
Scientists think that an imbalance in the complex, interrelated chemical reactions of the brain involving the neurotransmitters dopamine and glutamate, and possibly others, plays a role in schizophrenia.